Type 2 diabetes drug battle on tap
FDA approval for Merck’s Januvia today sets the stage for a major marketing battle in a new class of Type ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.